Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A highly multiplexed quantitative phosphosite assay for biology and preclinical studies. | Mol Syst Biol | 2021 | 34569154 | PubTator, text mining | PubMed |
| Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway. | Bioengineered | 2021 | 34565286 | PubTator, text mining | PubMed |
| Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis. | Oncol Rep | 2021 | 34549306 | PubTator, text mining | PubMed |
| Novel zebrafish polycystic kidney disease models reveal functions of the Hippo pathway in renal cystogenesis. | Dis Model Mech | 2021 | 34545930 | PubTator, text mining | PubMed |
| Alternative splicing regulation of cell-cycle genes by SPF45/SR140/CHERP complex controls cell proliferation. | RNA | 2021 | 34544891 | PubTator, text mining | PubMed |
| CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway. | J Transl Med | 2021 | 34544426 | PubTator, text mining | PubMed |
| lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis. | Oncol Rep | 2021 | 34542165 | PubTator, text mining | PubMed |
| The Hippo pathway: an emerging role in urologic cancers. | Am J Clin Exp Urol | 2021 | 34541029 | PubTator, text mining | PubMed |
| The regulatory networks of the Hippo signaling pathway in cancer development. | J Cancer | 2021 | 34539895 | PubTator, text mining | PubMed |
| A survey of RNA editing at single-cell resolution links interneurons to schizophrenia and autism. | RNA | 2021 | 34535545 | PubTator, text mining | PubMed |
| MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine. | Genes Dis | 2021 | 34522706 | PubTator, text mining | PubMed |
| Long non-coding RNA CCAT2 drives the growth of laryngeal squamous cell carcinoma via regulating YAP activity. | Hum Cell | 2021 | 34515990 | PubTator, text mining | PubMed |
| Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer. | Mol Ther Methods Clin Dev | 2021 | 34514028 | PubTator, text mining | PubMed |
| LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. | Mol Ther Nucleic Acids | 2021 | 34513310 | PubTator, text mining | PubMed |
| Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer. | Mol Med Rep | 2021 | 34505633 | PubTator, text mining | PubMed |
| A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer. | Cancers (Basel) | 2021 | 34503076 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Pathological significance and prognostic role of LATS2 in prostate cancer. | Prostate | 2021 | 34492128 | PubTator, text mining | PubMed |
| Circβ-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression. | Cell Death Discov | 2021 | 34489401 | PubTator, text mining | PubMed |
| Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential. | Mol Ther Nucleic Acids | 2021 | 34484862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=55